More Vitasora Health Limited news
Vitasora Health LimitedASX: VHL

iSonea Strengthens Leadership in Respiratory mHealth Tech

Mar 30, 2016 at 9:11 AM EDT · Issued by Vitasora Health Limited

Filed with ASX · Mar 30, 2016 at 9:11 AM EDT · 2 pages · English

On 6ix: 6ix.com/news/isonea-strengthens-leadership-in-respiratory-mhealth-tech

Vitasora Health Limited on 6ix

Earlier from Vitasora Health

  • Respiri - Market Update (Feb 2016)Feb 29, 2016
  • Respiri Appendix 4D and Interim Financial Report - Dec 2015Feb 28, 2016
  • Appendix 4C - Second Quarter Cash Report - FY2016Feb 11, 2016
  • Appendix 4E - Preliminary Final Report - June 2015Feb 10, 2016
  • Appendix 4E - Preliminary Final Report - June 2014Aug 29, 2014

Later from Vitasora Health

  • Respiri Announces $4.3M Fully Underwritten Rights IssueMay 18, 2016
  • Offer Booklet for Renounceable Pro-Rata Rights IssueMay 19, 2016
  • Respiri $4.3M Rights Issue Closes With SuccessJun 17, 2016
  • Independent Study Confirms AirSonea Detects Asthma WheezingJul 25, 2016
  • Appendix 4C - Fourth Quarter Cash Report - FY2016Jul 29, 2016
All Vitasora Health news releases↗

Follow Vitasora Health into a list and get an email when it puts out news.

Follow Vitasora Health
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer